Yinghua C. Ji
Xinxiang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
First-Line Serplulimab in Extensive-Stage Small Cell Lung Cancer: Secondary Analysis of the ASTRUM-005 Phase 3 Randomized Clinical Trial.
Journal: JAMA oncology
Published: June 04, 2026
Plain language summary: comparing ivonescimab plus chemotherapy with tislelizumab plus chemotherapy in people with advanced squamous non-small cell lung cancer in the HARMONi-6 study.
Journal: Future oncology (London, England)
Published: June 03, 2026
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (HARMONi-6): interim overall survival analysis of a randomised, double-blind, phase 3 trial in China.
Journal: Lancet (London, England)
Published: April 23, 2026
Expert consensus on the detection and clinical application of tumor mutational burden.
Journal: Cancer biology & medicine
Published: February 18, 2026
Buspirone hydrochloride: a potential regulator of PD-L1 for enhanced antitumor activity in melanoma-bearing mice.
Journal: Journal of drug targeting
Published: January 05, 2026
Examining the Risk and Psychosocial Intervention for Suicidal Behavior and Death Among People With Cancer: A Systematic Review and Meta-Analysis.
Journal: Psycho-oncology
Published: January 05, 2026
KRAS mutations reshape the immunosuppressive tumor microenvironment in triple-negative breast cancer: A novel perspective.
Journal: Critical reviews in oncology/hematology
Published: November 27, 2025
Aumolertinib with or without chemotherapy in EGFR-mutated advanced non-small-cell lung cancer (AENEAS2): an open-label, multicentre, randomised, controlled, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 24, 2025
Detection of circulating hybrid cells and circulating tumor cells in cerebrospinal fluid for leptomeningeal metastasis diagnosis and therapeutic prediction.
Journal: Frontiers in cell and developmental biology
Published: September 30, 2025
Tumor-to-Tumor Metastasis: Breast Cancer Metastasizing to EGFR Exon 19-Mutated Lung Adenocarcinoma with Long-Term Disease-Free Survival.
Journal: Biologics : targets & therapy
Published: August 12, 2025
Case Report: Anlotinib combined with radiotherapy achieves sustained disease control in advanced malignant melanotic nerve sheath tumor.
Journal: Frontiers in oncology
Published: August 06, 2025
Last Updated: 09/26/2026